Last $6.18 USD
Change Today -0.09 / -1.44%
Volume 10.0K
TNXP On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

tonix pharmaceuticals holdin (TNXP) Snapshot

Open
$6.27
Previous Close
$6.27
Day High
$6.38
Day Low
$6.12
52 Week High
01/13/14 - $21.00
52 Week Low
10/20/14 - $5.33
Market Cap
66.6M
Average Volume 10 Days
71.6K
EPS TTM
$-2.64
Shares Outstanding
10.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TONIX PHARMACEUTICALS HOLDIN (TNXP)

Related News

No related news articles were found.

tonix pharmaceuticals holdin (TNXP) Related Businessweek News

No Related Businessweek News Found

tonix pharmaceuticals holdin (TNXP) Details

Tonix Pharmaceuticals Holding Corp., a development stage specialty pharmaceutical company, focuses on the identification and development of pharmaceutical products for the disorders of central nervous system. The company’s lead product candidate, TNX-102 sublingual tablet, is a dosage formulation of cyclobenzaprine for the treatment of fibromyalgia and post-traumatic stress disorder. It also has a pipeline of various other product candidates, including TNX-201, which is a treatment for certain types of episodic tension-type headache; and TNX-301 that is indicated for the treatment of alcohol abuse and dependence. The company was founded in 2007 and is headquartered in New York, New York.

6 Employees
Last Reported Date: 03/28/14
Founded in 2007

tonix pharmaceuticals holdin (TNXP) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: $277.5K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $314.2K
Chief Scientific Officer, Secretary and Contr...
Total Annual Compensation: $238.2K
Compensation as of Fiscal Year 2013.

tonix pharmaceuticals holdin (TNXP) Key Developments

Tonix Pharmaceuticals Holding Corp Presents at LD Micro Conference, Dec-02-2014 08:00 AM

Tonix Pharmaceuticals Holding Corp Presents at LD Micro Conference, Dec-02-2014 08:00 AM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Boulevard, Los Angeles, California, United States. Speakers: Seth Lederman, Co-Founder, Chairman, Chief Executive Officer and President.

Tonix Pharmaceuticals Holding Corp Reports Unaudited Consolidated Earnings Results for Third Quarter and Nine Months Ended September 30, 2014

Tonix Pharmaceuticals Holding Corp. reported unaudited consolidated earnings results for third quarter and nine months ended September 30, 2014. For the quarter, the company’s operating loss was $7,434,000 against $3,092,000 a year ago. Net loss was $7,419,000 or $0.71 per basic and diluted share against $3,090,000 or $0.87 per basic and diluted share a year ago. The increase in net loss is primarily due to an increase in research and development expense. For the nine months, the company’s operating loss was $18,652,000 against $7,179,000 a year ago. Net loss was $18,627,000 or $1.92 per basic and diluted share against $7,177,000 or $2.73 per basic and diluted share a year ago.

Tonix Pharmaceuticals Holding Corp Presents at Boston Biotech NY/NJ CEO Conference, Nov-13-2014 03:15 PM

Tonix Pharmaceuticals Holding Corp Presents at Boston Biotech NY/NJ CEO Conference, Nov-13-2014 03:15 PM. Venue: Apella, 450 East 29th Street, New York, New York, United States. Speakers: Leland Gershell, Chief Financial Officer, Principal Accounting Officer and Treasurer.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TNXP:US $6.18 USD -0.09

TNXP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TNXP.
View Industry Companies
 

Industry Analysis

TNXP

Industry Average

Valuation TNXP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 1.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TONIX PHARMACEUTICALS HOLDIN, please visit www.tonixpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.